Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care DeliveryDigital TransformationPrecision MedicineRemote Monitoring and Telehealth.

ACC Corner: Industry Relationships - Conflict of Interest or Scientific Survival?

Much has been made about conflicts of interests in the medical communitys relationships with industry. This includes relationships with physicians as well as those with medical schools and professional organizations. Some reports, in fact, suggest egregious findings that make all of us concerned. Transparency about our relationships with industry is critical to a fair and balanced review of available science.

The Death of CME as We Know It?

A variety of ills would ensue if industry support for meetings dried up.

Practice Management Software Moves Beyond Bean Counting

Its not the data that are necessarily importantits what you do with that data, and practices are discovering more ways to use their management resources intelligently.

NovaRad completes RIS contract with N.Y. imaging center

Ramapo Practice Management, an imaging center in Monroe, N.Y., has selected NovaRIS from NovaRad.

Diamonds in the Rough

Among the plethora of clinical trials and analysis presented at this years Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, a few reports were of particular interest to the interventional cardiology community.

HORIZONS AMI finds DES more effective, as safe as BMS at one year

WASHINGTONAfter one year, use of a drug-eluting stent (DES) in heart attack patients demonstrated significantly reduced rates of target lesion revascularization (TLR) and binary angiographic restenosis when compared to the use of a bare metal stent (BMS), according to the HORIZONS AMI trial presented Wednesday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

SYNTAX data enlightens treatment choices for left main, three-vessel diseases; develops new scoring

WASHINGTON, D.C.There are similar safety and efficacy outcomes when the use of a drug-eluting stent (DES) is compared to CABG in patients with left main disease and three-vessel disease (3VD), according to newly reported SYNTAX data presented Tuesday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Taxus equates to BMS in treating saphenous vein graft lesions

WASHINGTON, D.C.Boston Scientifics Taxus paclitaxel-eluting stent (PES) had very similar clinical outcomes and safety features compared to bare-metal stents (BMS) in treating saphenous vein graft lesions, according to a late breaking clinical trial presented Tuesday at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.